Last updated 2026-08-21
- Raised $200k grant, May 2019
- Raised $625k grant led by NIH
Total raised
$825K
Stage
—
Founded
2011
Headcount
—
HQ
Manassas, VA, United States
Sector
Drug Discovery
About
Serpin Pharma is a clinical-stage biopharmaceutical company focused on developing first-in-class immune-modulating therapeutics for inflammatory diseases. The company's lead therapeutic, SP16, is a modified peptide derived from alpha-1 antitrypsin (AAT) that aims to restore immune balance by targeting a key immune-regulating receptor, LRP1. SP16 is undergoing pre-clinical and clinical trials for various indications, including acute kidney injury (AKI), acute myocardial infarction (AMI), and chemotherapy-induced peripheral neuropathy (CIPN).
Funding history · 2 rounds · $825K total
2 events/rounds · $825K Total Funding
May 2019
Date unknown
★ NIH
Offices
Manassas, VA, United States · HQ / main office
Q&A
- What is Serpin Pharma LLC's primary focus?
- Serpin Pharma LLC is a clinical-stage biopharmaceutical company focused on developing first-in-class immune-modulating therapeutics for inflammatory diseases.
- What is Serpin Pharma LLC's lead therapeutic candidate?
- Serpin Pharma LLC's lead therapeutic, SP16, is a modified peptide derived from alpha-1 antitrypsin (AAT) that aims to restore immune balance by targeting the LRP1 receptor.
- For which indications is SP16 undergoing trials?
- SP16 is undergoing pre-clinical and clinical trials for various indications, including acute kidney injury (AKI), acute myocardial infarction (AMI), and chemotherapy-induced peripheral neuropathy (CIPN).
- When was Serpin Pharma LLC founded?
- Serpin Pharma LLC was founded in 2011.
- Who is the founder and CEO of Serpin Pharma LLC?
- Cohava Gelber is the Founder, Executive Chairperson, and CEO of Serpin Pharma LLC, a position she has held since 2011.
- What is the total amount of funding Serpin Pharma LLC has raised?
- Serpin Pharma LLC has raised a total of $825,359 through grant funding.
- Which organization provided a grant to Serpin Pharma LLC?
- Serpin Pharma LLC received a grant of $625,359 from NIH.
- What is Serpin Pharma LLC's affiliation with Dogwood Therapeutics?
- Dogwood Therapeutics has a global license to develop and commercialize SP16 for intravenous administration in cancer patients.
- Who is a recent addition to Serpin Pharma LLC's Board of Directors?
- Alexander Fleming was appointed as a Board Member at Serpin Pharma LLC in January 2024.
Sectors & technology
Primary sector
Drug Discovery
Technologies
Target customers
Business model
Biopharmaceutical DevelopmentDrug Commercialization
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | www.serpinpharma.com |
|---|
Identifiers & details
| Legal name | Serpin Pharma, Inc. |
|---|---|
| Founded | 2011 |
Radar intelligence
Patents
| EPO | 6 |
|---|
Web history (Wayback)
| Domain | serpinpharma.com |
|---|